These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21594967)

  • 1. Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma.
    Llovet JM; Paradis V; Kudo M; Zucman-Rossi J
    Liver Transpl; 2011 Oct; 17 Suppl 2(Suppl 2):S67-71. PubMed ID: 21594967
    [No Abstract]   [Full Text] [Related]  

  • 2. Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?
    Gouw AS; Balabaud C; Kusano H; Todo S; Ichida T; Kojiro M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S72-80. PubMed ID: 21714066
    [No Abstract]   [Full Text] [Related]  

  • 3. What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?
    Olthoff KM; Forner A; Hübscher S; Fung J
    Liver Transpl; 2011 Oct; 17 Suppl 2():S26-33. PubMed ID: 21656653
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver Transplant for Hepatocellular Carcinoma: Pathologic Point Of View.
    Özgün G; Haberal Reyhan N; Özdemir BH; Haberal M
    Exp Clin Transplant; 2017 Mar; 15(Suppl 2):50-54. PubMed ID: 28301999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular cancer: how to expand safely inclusion criteria for liver transplantation.
    Lai Q; Lerut JP
    Curr Opin Organ Transplant; 2014 Jun; 19(3):229-34. PubMed ID: 24811435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging diagnosis and staging of hepatocellular carcinoma.
    Lee JM; Trevisani F; Vilgrain V; Wald C
    Liver Transpl; 2011 Oct; 17 Suppl 2():S34-43. PubMed ID: 21739567
    [No Abstract]   [Full Text] [Related]  

  • 7. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience.
    Mazzaferro V; Bhoori S; Sposito C; Bongini M; Langer M; Miceli R; Mariani L
    Liver Transpl; 2011 Oct; 17 Suppl 2():S44-57. PubMed ID: 21695773
    [No Abstract]   [Full Text] [Related]  

  • 8. Is tumor biopsy necessary?
    Müllhaupt B; Durand F; Roskams T; Dutkowski P; Heim M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S14-25. PubMed ID: 21744470
    [No Abstract]   [Full Text] [Related]  

  • 9. Selection of candidates with HCC for transplantation in the MELD era.
    Sala M; Varela M; Bruix J
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S4-9. PubMed ID: 15382217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation for hepatocellular carcinoma.
    Berumen J; Hemming A
    Abdom Radiol (NY); 2018 Jan; 43(1):185-192. PubMed ID: 28634617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: necessity or option?
    Fujiki M; Aucejo F; Kim R
    Liver Int; 2011 Sep; 31(8):1081-9. PubMed ID: 22008644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Transplantation for Hepatocellular Carcinoma Beyond the Milan Criteria.
    Gunsar F
    Exp Clin Transplant; 2017 Mar; 15(Suppl 2):59-64. PubMed ID: 28302001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma: current management and perspectives for the future.
    Rahbari NN; Mehrabi A; Mollberg NM; Müller SA; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):453-69. PubMed ID: 21263310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation for hepatocellular carcinoma after down staging with sorafenib: a monocentric case-matched series.
    Palen A; Grégoire E; Chopinet S; Borentain P; Gerolami R; Hardwigsen J
    J Gastrointestin Liver Dis; 2020 Mar; 29(1):120-121. PubMed ID: 32176754
    [No Abstract]   [Full Text] [Related]  

  • 15. Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy.
    Han LL; Lv Y; Guo H; Ruan ZP; Nan KJ
    World J Gastroenterol; 2014 Aug; 20(30):10249-61. PubMed ID: 25132742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can metallothionein be a useful molecular marker for selecting hepatocellular carcinoma patients for platinum-based chemotherapy?
    Doki Y; Monden M
    J Gastroenterol; 2004 Dec; 39(12):1228-9. PubMed ID: 15622495
    [No Abstract]   [Full Text] [Related]  

  • 17. Should the selection of children with hepatocellular carcinoma be based on Milan criteria?
    Otte JB
    Pediatr Transplant; 2008 Feb; 12(1):1-3. PubMed ID: 18086239
    [No Abstract]   [Full Text] [Related]  

  • 18. Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?
    Yao FY; Breitenstein S; Broelsch CE; Dufour JF; Sherman M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S109-16. PubMed ID: 21584927
    [No Abstract]   [Full Text] [Related]  

  • 19. HCC criteria for liver transplantation: Controversies.
    Burra P; Zanetto A; Rodriguez-Castro KI
    Liver Transpl; 2015 Nov; 21 Suppl 1():S27-31. PubMed ID: 26224651
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision.
    Bruix J; Fuster J; Llovet JM
    Liver Transpl; 2003 Jul; 9(7):700-2. PubMed ID: 12827556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.